Absorbable Endoureteral Stent Advanced Development and Pilot Production: A 12-Month Program Agreement Outline Prepared for Valera Pharmaceuticals, Inc. Issued: March 24, 2006 Revised: April 10, 2006Valera Pharmaceuticals Inc • December 11th, 2006 • Pharmaceutical preparations
This document entails (1) background and specific aims of the 12-month program; (2) an outline of major experimental segments; (3) target dates for completion of program segments; (4) program monitoring and review, (5) program budget and disbursement schedule; (6) licensing and manufacturing agreements; and (7) contingency plans.
